BeOne Medicines (BEIGF) Return on Capital Employed Growth (1y) (2017 - 2026)
BeOne Medicines (BEIGF) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
31,429.00 |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
16,829.00 |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
1,805.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
1,805.00 |
| Dec 31, 2025 |
2,287.00 |
| Sep 30, 2025 |
2,727.00 |
| Jun 30, 2025 |
2,102.00 |
| Mar 31, 2025 |
2,089.00 |
| Dec 31, 2024 |
1,581.00 |
| Sep 30, 2024 |
647.00 |
| Jun 30, 2024 |
1,236.00 |
| Mar 31, 2024 |
999.00 |
| Dec 31, 2023 |
318.00 |
| Sep 30, 2023 |
-972.00 |
| Jun 30, 2023 |
-1,767.00 |
| Mar 31, 2023 |
-2,123.00 |
| Dec 31, 2022 |
-2,177.00 |
| Sep 30, 2022 |
1,293.00 |
| Jun 30, 2022 |
1,169.00 |
| Mar 31, 2022 |
916.00 |
| Dec 31, 2021 |
2,403.00 |
| Sep 30, 2021 |
520.00 |
| Jun 30, 2021 |
1,171.00 |
